查看購物車
  • English
  • Japanese
  • Korean
全球體外膜氧合（ECMO）設備市場（2026-2030 年）
市場調查報告書
商品編碼
2125881

全球體外膜氧合（ECMO）設備市場（2026-2030 年）

Global Extracorporeal Membrane Oxygenation Machines Market 2026-2030
出版日期: | 出版商: TechNavio | 英文 297 Pages | 訂單完成後即時交付

價格
簡介目錄

全球體外膜氧合（ECMO）設備市場預計將從 2025 年到 2030 年成長至 1.615 億美元，預測期內複合年成長率為 5.9%。

本報告對全球體外膜氧合（ECMO）設備市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及涵蓋約 25 家供應商的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。該市場的成長主要受心肺疾病盛行率上升、體外生命支持設備技術進步以及專業急救醫療方案和體外心肺復甦術（ECPR）方案的推廣應用所驅動。

本報告基於客觀的綜合分析，結合一手和二手資料，包括主要產業相關人員的意見。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場資訊及區域分析，以及供應商格局。此外，報告還包含歷史數據和預測數據。

市場範圍
基準年 2025
年末 2030
預測期 2026-2030
成長勢頭 加速度
年比比較（2026 年） 5.7%
複合年成長率 5.9%
增量 1.615億美元

本報告指出，人工智慧和機器學習技術在體外膜氧合（ECMO）設備中的應用，是未來幾年全球ECMO設備市場成長的關鍵促進因素之一。此外，支援設備的微型化和移動性提升，以及專用體外生命維持中心的擴建，預計也將帶來顯著的市場需求。

目錄

第1章：執行摘要

第2章：Technavio 的分析

  • 分析價格敏感度、生命週期、顧客購買籃子、採用率和購買標準。
  • 輸入的重要性及差異化因素
  • 混淆因素
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模評估

  • 市場的定義
  • 市場區隔分析
  • 市場規模（2025 年）
  • 市場展望（2025-2030 年）

第5章 市場規模與表現

  • 全球體外膜氧合（ECMO）設備市場（2020-2024）
  • 按產品分類的分析（2020-2024 年）
  • 按模態分類的分析（2020-2024）
  • 按應用領域分析（2020-2024 年）
  • 區域分析（2020-2024）
  • 各國分析（2020-2024 年）

第6章 定性分析

  • 人工智慧的影響：全球體外膜氧合（ECMO）設備市場
  • 地緣政治衝突對全球體外膜氧合（ECMO）設備市場的影響。

第7章：五力分析

第8章 市場區隔：依產品

  • 比較：按產品
  • ECMO裝置
  • 成分
  • 市場機會：依產品分類

第9章 市場區隔：依治療方式

  • 比較：依模態
  • 靜脈-靜脈 (VV) 和動脈-靜脈 (AV)
  • 靜脈-動脈（VA）
  • 市場機會：依治療方式分類

第10章 市場區隔：依應用領域

  • 比較：按應用
  • 呼吸系統
  • 心
  • ECPR（體外循環心肺復甦術）
  • 市場機會：依應用領域分類

第11章 客戶情況

第12章 區域情勢

  • 區域分類
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
  • 其他地區（ROW）
    • 巴西
    • 沙烏地阿拉伯
    • UAE
    • 土耳其
    • 阿根廷
    • 哥倫比亞
    • 南非
    • 以色列
  • 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第14章 競爭格局

  • 概述
  • 競爭格局
  • 混亂局面
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 公司排名指標
  • 企業市場定位
  • Abbott Laboratories
  • Berlin Heart GmbH
  • Chalice Medical Ltd.
  • Eurosets Srl
  • Getinge AB
  • Heal Force Biomeditech Holdings
  • LivaNova PLC
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Nihon Kohden Corp.
  • Nipro Medical Corp.
  • Spectrum Medical Ltd.
  • SynCardia Systems LLC
  • Terumo Corp.
  • Transonic Systems Inc.

第16章附錄

簡介目錄
Product Code: IRTNTR40185

The global extracorporeal membrane oxygenation machines market is forecasted to grow by USD 161.5 mn during 2025-2030, accelerating at a CAGR of 5.9% during the forecast period. The report on the global extracorporeal membrane oxygenation machines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiopulmonary disorders, technological advancements in extracorporeal life support consoles, expansion of specialized emergency and ecpr protocols.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 20265.7%
CAGR5.9%
Incremental Value$161.5 mn

Technavio's global extracorporeal membrane oxygenation machines market is segmented as below:

By Product

  • ECMO machines
  • Components

By Modality

  • Veno-venous and arterio-venous
  • Veno-arterial

By Application

  • Respiratory
  • Cardiac
  • ECPR

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
  • Asia
  • Rest of World (ROW)
  • Rest of World (ROW)

This study identifies the integration of ai and ml in machines as one of the prime reasons driving the global extracorporeal membrane oxygenation machines market growth during the next few years. Also, miniaturization and enhanced mobility of support units and expansion of dedicated extracorporeal life support centers will lead to sizable demand in the market.

The report on the global extracorporeal membrane oxygenation machines market covers the following areas:

  • Global extracorporeal membrane oxygenation machines market sizing
  • Global extracorporeal membrane oxygenation machines market forecast
  • Global extracorporeal membrane oxygenation machines market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global extracorporeal membrane oxygenation machines market vendors that include Abbott Laboratories, Berlin Heart GmbH, Braile Biomedica, Chalice Medical Ltd., Eurosets Srl, Getinge AB, Heal Force Biomeditech Holdings, Hemovent GmbH, LivaNova PLC, Medtronic Plc, MicroPort Scientific Corp., Mizuho Corp., Nihon Kohden Corp., Nipro Medical Corp., OriGen Biomedical, Spectrum Medical Ltd., SynCardia Systems LLC, Terumo Corp., Transonic Systems Inc., Xenios AG. Also, the global extracorporeal membrane oxygenation machines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Modality
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Extracorporeal Membrane Oxygenation Machines Market 2020 - 2024
    • Historic Market Size - Data Table on Global Extracorporeal Membrane Oxygenation Machines Market 2020 - 2024 ($ million)
  • 5.2 Product segment analysis 2020 - 2024
    • Historic Market Size - Product Segment 2020 - 2024 ($ million)
  • 5.3 Modality segment analysis 2020 - 2024
    • Historic Market Size - Modality Segment 2020 - 2024 ($ million)
  • 5.4 Application segment analysis 2020 - 2024
    • Historic Market Size - Application Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on global extracorporeal membrane oxygenation machines market
  • 6.2 Impact of geopolitical conflicts on global extracorporeal membrane oxygenation machines market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Product

  • 8.1 Market segments
  • 8.2 Comparison by Product
  • 8.3 ECMO machines - Market size and forecast 2025-2030
  • 8.4 Components - Market size and forecast 2025-2030
  • 8.5 Market opportunity by Product
    • Market opportunity by Product ($ million)

9 Market Segmentation by Modality

  • 9.1 Market segments
  • 9.2 Comparison by Modality
  • 9.3 Veno-venous and arterio-venous - Market size and forecast 2025-2030
  • 9.4 Veno-arterial - Market size and forecast 2025-2030
  • 9.5 Market opportunity by Modality
    • Market opportunity by Modality ($ million)

10 Market Segmentation by Application

  • 10.1 Market segments
  • 10.2 Comparison by Application
  • 10.3 Respiratory - Market size and forecast 2025-2030
  • 10.4 Cardiac - Market size and forecast 2025-2030
  • 10.5 ECPR - Market size and forecast 2025-2030
  • 10.6 Market opportunity by Application
    • Market opportunity by Application ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 UK - Market size and forecast 2025-2030
    • 12.4.3 France - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 Spain - Market size and forecast 2025-2030
    • 12.4.6 The Netherlands - Market size and forecast 2025-2030
  • 12.5 Asia - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 India - Market size and forecast 2025-2030
    • 12.5.3 Japan - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Indonesia - Market size and forecast 2025-2030
    • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
    • 12.6.1 Brazil - Market size and forecast 2025-2030
    • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.3 UAE - Market size and forecast 2025-2030
    • 12.6.4 Turkey - Market size and forecast 2025-2030
    • 12.6.5 Argentina - Market size and forecast 2025-2030
    • 12.6.6 Colombia - Market size and forecast 2025-2030
    • 12.6.7 South Africa - Market size and forecast 2025-2030
    • 12.6.8 Israel - Market size and forecast 2025-2030
  • 12.7 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Rising prevalence of cardiopulmonary disorders
    • Technological advancements in extracorporeal life support consoles
    • Expansion of specialized emergency and ECPR protocols
  • 13.2 Market challenges
    • High equipment and operational costs
    • Dearth of skilled and specialized professionals
    • Inherent technical risks and device complications
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Integration of AI and ML in machines
    • Miniaturization and enhanced mobility of support units
    • Expansion of dedicated extracorporeal life support centers

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 15.5 Berlin Heart GmbH
    • Berlin Heart GmbH - Overview
    • Berlin Heart GmbH - Product / Service
    • Berlin Heart GmbH - Key offerings
    • SWOT
  • 15.6 Chalice Medical Ltd.
    • Chalice Medical Ltd. - Overview
    • Chalice Medical Ltd. - Product / Service
    • Chalice Medical Ltd. - Key offerings
    • SWOT
  • 15.7 Eurosets Srl
    • Eurosets Srl - Overview
    • Eurosets Srl - Product / Service
    • Eurosets Srl - Key offerings
    • SWOT
  • 15.8 Getinge AB
    • Getinge AB - Overview
    • Getinge AB - Business segments
    • Getinge AB - Key offerings
    • Getinge AB - Segment focus
    • SWOT
  • 15.9 Heal Force Biomeditech Holdings
    • Heal Force Biomeditech Holdings - Overview
    • Heal Force Biomeditech Holdings - Product / Service
    • Heal Force Biomeditech Holdings - Key offerings
    • SWOT
  • 15.10 LivaNova PLC
    • LivaNova PLC - Overview
    • LivaNova PLC - Business segments
    • LivaNova PLC - Key offerings
    • LivaNova PLC - Segment focus
    • SWOT
  • 15.11 Medtronic Plc
    • Medtronic Plc - Overview
    • Medtronic Plc - Business segments
    • Medtronic Plc - Key news
    • Medtronic Plc - Key offerings
    • Medtronic Plc - Segment focus
    • SWOT
  • 15.12 MicroPort Scientific Corp.
    • MicroPort Scientific Corp. - Overview
    • MicroPort Scientific Corp. - Business segments
    • MicroPort Scientific Corp. - Key offerings
    • MicroPort Scientific Corp. - Segment focus
    • SWOT
  • 15.13 Nihon Kohden Corp.
    • Nihon Kohden Corp. - Overview
    • Nihon Kohden Corp. - Business segments
    • Nihon Kohden Corp. - Key offerings
    • Nihon Kohden Corp. - Segment focus
    • SWOT
  • 15.14 Nipro Medical Corp.
    • Nipro Medical Corp. - Overview
    • Nipro Medical Corp. - Business segments
    • Nipro Medical Corp. - Key offerings
    • Nipro Medical Corp. - Segment focus
    • SWOT
  • 15.15 Spectrum Medical Ltd.
    • Spectrum Medical Ltd. - Overview
    • Spectrum Medical Ltd. - Product / Service
    • Spectrum Medical Ltd. - Key offerings
    • SWOT
  • 15.16 SynCardia Systems LLC
    • SynCardia Systems LLC - Overview
    • SynCardia Systems LLC - Product / Service
    • SynCardia Systems LLC - Key offerings
    • SWOT
  • 15.17 Terumo Corp.
    • Terumo Corp. - Overview
    • Terumo Corp. - Business segments
    • Terumo Corp. - Key news
    • Terumo Corp. - Key offerings
    • Terumo Corp. - Segment focus
    • SWOT
  • 15.18 Transonic Systems Inc.
    • Transonic Systems Inc. - Overview
    • Transonic Systems Inc. - Product / Service
    • Transonic Systems Inc. - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations